Fred Alger Management
FTH icon

Fred Alger Management’s Faeth Therapeutics FTH Stock Holding History

Fred Alger Management’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,337
Closed -$578K – 491
2026
Q1 		$578K Buy
+18,337
New +$366K ﹤0.01% 377

Other funds holding FTH

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Fairmount Funds Management
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Logos Global Management
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Fred Alger Management's FTH Position: Q2 2026 in Review

Fred Alger Management sold out of Faeth Therapeutics (FTH) in Q2 2026, closing a stake of 18,337 shares — an estimated $578K sold.

Fred Alger Management first reported a position in FTH in Q1 2026 and held it in 1 quarter. The position peaked at $578K in Q1 2026. 45 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

  • Fred Alger Management reported no remaining Faeth Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Fred Alger Management sold 18,337 Faeth Therapeutics shares in Q2 2026, an estimated $578K.
  • Fred Alger Management first reported a position in Faeth Therapeutics in Q1 2026 and held it in 1 quarter.
  • Fred Alger Management's Faeth Therapeutics position peaked at $578K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.